Tilman M Hackeng

Summary

Affiliation: Maastricht University
Country: The Netherlands

Publications

  1. ncbi Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S
    T M Hackeng
    Departments of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
    Biochem J 349:757-64. 2000
  2. ncbi Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S
    T M Hackeng
    Department of Molecular and Experimental Medicine, Skaggs Institute for Chemical Biology, La Jolla, CA 92037, USA
    Proc Natl Acad Sci U S A 97:14074-8. 2000
  3. ncbi Total chemical synthesis of human matrix Gla protein
    T M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, The Netherlands
    Protein Sci 10:864-70. 2001
  4. ncbi Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor
    Tilman M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University of Maastricht, The Netherlands
    Proc Natl Acad Sci U S A 103:3106-11. 2006
  5. ncbi Regulation of TFPI function by protein S
    T M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht CARIM, Maastricht University, Maastricht, The Netherlands
    J Thromb Haemost 7:165-8. 2009
  6. ncbi Effect of oral contraceptives on the anticoagulant activity of protein S in plasma
    Rory R Koenen
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, The Netherlands
    Thromb Haemost 93:853-9. 2005
  7. ncbi Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance
    Kristin M Seré
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, 6200 MD Maastricht, The Netherlands
    Blood 104:3624-30. 2004
  8. ncbi The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities
    Rory R Koenen
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, The Netherlands
    Thromb Haemost 91:1105-14. 2004
  9. ncbi The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa
    Subramanian Yegneswaran
    Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA
    J Biol Chem 283:33046-52. 2008
  10. ncbi Protein S as cofactor for TFPI
    Tilman M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, Maastricht, The Netherlands
    Arterioscler Thromb Vasc Biol 29:2015-20. 2009

Collaborators

  • Jan Rosing
  • Kim Douma
  • Mark J Post
  • Lenneke Prinzen
  • Sylvia Heeneman
  • Elisabetta Castoldi
  • Bjorn Dahlback
  • Marc B I Lobbes
  • Martijn Kwaijtaal
  • Jose W P Govers-Riemslag
  • George M Willems
  • Gerry A F Nicolaes
  • J A Fernandez
  • Cees Vermeer
  • G Tans
  • Vincent Matthias Brandenburg
  • M Ketteler
  • L J Schurgers
  • C P Reutelingsperger
  • Anouk Dirksen
  • Marc A M J van Zandvoort
  • Rory R Koenen
  • Marlies Oostendorp
  • Mat J A P Daemen
  • Philip E Dawson
  • Hilde Laeremans
  • Ben J A Janssen
  • Merlijn J P M T Meens
  • Walter H Backes
  • Pieter Van de Vijver
  • Julian Ilcheff Borissoff
  • Hugo ten Cate
  • Robbert Jan J H M Miserus
  • Ellen C M Cranenburg
  • Kitty B J M Cleutjens
  • Subramanian Yegneswaran
  • Lisbeth F A Maurissen
  • Rene van Oerle
  • Karly Hamulyak
  • Alexandra Buehler
  • Cecile V Denis
  • Kristin M Seré
  • W Matthijs Blankesteijn
  • Victor L J L Thijssen
  • Harry C J Ottenheijm
  • Jos F M Smits
  • Marc A van Zandvoort
  • Matthijs G Compeer
  • Henri M H Spronk
  • Kristien Winckers
  • Jo G R De Mey
  • Dennis Suylen
  • Peter Kassák
  • Evren Kilinc
  • M Veronica Herias
  • Robert Jan van Suylen
  • Marianne Eline Kooi
  • Johan W M Heemskerk
  • Jos M A van Engelshoven
  • Freek G Bouwman
  • Marie-Louise Boumans
  • Johannes Waltenberger
  • Veerle Somers
  • John H Griffin
  • Mat Rousch
  • M Christella L G D Thomassen
  • Marie Louise Boumans
  • Darcey Black
  • Vadim Tchaikovski
  • Peter J E H M Kitslaar
  • Anneke Sijbers
  • Birgit C G Faber
  • Piet Geusens
  • Ruben van Doorn
  • Ralf Koos
  • Cornelis Vink
  • Ebo D de Muinck
  • Adriaan Duijvestijn
  • Bianca H G J Schrans-Stassen
  • Dominique P V de Kleijn
  • Abdelkader Bennaghmouch
  • Mirjam B Smeets
  • Bram J Stelt
  • Sjoerd Dirksen
  • Jack P M Cleutjens
  • Leo Hofstra
  • M Christella
  • Peter J Lenting
  • L G D Thomassen
  • Sarah J Roberts

Detail Information

Publications32

  1. ncbi Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S
    T M Hackeng
    Departments of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
    Biochem J 349:757-64. 2000
    ..Thus we provide direct evidence for binding of protein S-EGF1 to APC and show that it induces a conformational change in APC...
  2. ncbi Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S
    T M Hackeng
    Department of Molecular and Experimental Medicine, Skaggs Institute for Chemical Biology, La Jolla, CA 92037, USA
    Proc Natl Acad Sci U S A 97:14074-8. 2000
    ..These results demonstrate that total chemical synthesis of proteins offers an effective way to generate multidomain biologically active proteins...
  3. ncbi Total chemical synthesis of human matrix Gla protein
    T M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, The Netherlands
    Protein Sci 10:864-70. 2001
    ..In conclusion, facile and efficient chemical synthesis in combination with native chemical ligation yielded MGP preparations that can aid in unraveling the mechanism by which MGP prevents vascular calcification...
  4. ncbi Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor
    Tilman M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University of Maastricht, The Netherlands
    Proc Natl Acad Sci U S A 103:3106-11. 2006
    ..Our data suggest that protein S deficiency not only increases the risk of thrombosis by impairing the protein C system but also by reducing the ability of TFPI to down-regulate the extrinsic coagulation pathway...
  5. ncbi Regulation of TFPI function by protein S
    T M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht CARIM, Maastricht University, Maastricht, The Netherlands
    J Thromb Haemost 7:165-8. 2009
    ....
  6. ncbi Effect of oral contraceptives on the anticoagulant activity of protein S in plasma
    Rory R Koenen
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, The Netherlands
    Thromb Haemost 93:853-9. 2005
    ..Functional impairment of protein S as a result of hormonal influence may, at least in part, contribute to the thrombotic risk of OC users...
  7. ncbi Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance
    Kristin M Seré
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, 6200 MD Maastricht, The Netherlands
    Blood 104:3624-30. 2004
    ....
  8. ncbi The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities
    Rory R Koenen
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, The Netherlands
    Thromb Haemost 91:1105-14. 2004
    ....
  9. ncbi The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa
    Subramanian Yegneswaran
    Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA
    J Biol Chem 283:33046-52. 2008
    ..In controls, the TSR domain did not alter the anisotropy of DEGR-fIXa(i) and DEGR-fVIIa(i), respectively. These data demonstrate that membrane-bound fXa binding to protein S involves the TSR of protein S...
  10. ncbi Protein S as cofactor for TFPI
    Tilman M Hackeng
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, Maastricht, The Netherlands
    Arterioscler Thromb Vasc Biol 29:2015-20. 2009
    ..The current review describes the background of the TFPI-cofactor activity of protein S as well as the rationale for the observation that the TFPI/protein S system particularly inhibits the TF pathway at low procoagulant stimuli...
  11. ncbi Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent
    Robbert Jan J H M Miserus
    Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands
    JACC Cardiovasc Imaging 2:987-96. 2009
    ..We aimed to investigate whether early thrombus formation can be visualized with in vivo magnetic resonance imaging (MRI) by the use of a novel bimodal alpha(2)-antiplasmin-based contrast agent (CA)...
  12. ncbi Gadolinium-labeled quantum dots for molecular magnetic resonance imaging: R1 versus R2 mapping
    Marlies Oostendorp
    Department of Radiology, Maastricht University Medical Centre MUMC, Maastricht, The Netherlands
    Magn Reson Med 64:291-8. 2010
    ..At a field strength of 7 T, longitudinal relaxation rate-based measures were superior to transverse relaxation rate-based measures in detecting both the level and spatial extent of contrast agent-induced relaxation rate changes...
  13. ncbi Early atherosclerosis exhibits an enhanced procoagulant state
    Julian Ilcheff Borissoff
    Laboratory for Clinical Thrombosis and Hemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Universiteitsingel 50, PO Box 616, Box 8, 6200 MD Maastricht, The Netherlands
    Circulation 122:821-30. 2010
    ..In the present study, we examined for the first time the activity and presence of relevant coagulation proteins in relation to the progression of atherosclerosis...
  14. ncbi Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
    Lisbeth F A Maurissen
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, Maastricht, The Netherlands
    Blood 111:3034-41. 2008
    ..These results are of interest for carriers of the factor V(Leiden) mutation (R(506)Q), as protein S-C4BP effectively enhances APC-catalyzed factor Va (R(306)) inactivation in plasma containing factor V(Leiden)...
  15. ncbi Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging
    Marlies Oostendorp
    Department of Radiology, Maastricht University Medical Centre MUMC, Maastricht, The Netherlands
    Contrast Media Mol Imaging 5:9-17. 2010
    ..Summarizing, molecular DCE-MRI with pharmacokinetic modeling provides unique information on contrast agent delivery and angiogenic activity in tumors...
  16. ncbi The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation
    Rory R Koenen
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, 6200 MD Maastricht, The Netherlands
    Blood 102:1686-92. 2003
    ..47 +/- 0.21; n = 46). We propose that the decreased APC-independent anticoagulant activity of protein S in plasma with elevated prothrombin levels may contribute to the thrombotic risk associated with the prothrombin G20210A mutation...
  17. ncbi Nanoparticles for optical molecular imaging of atherosclerosis
    Kim Douma
    Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
    Small 5:544-57. 2009
    ..In this review, we provide an overview of both current optical nanoparticles and targeting ligands for optical molecular imaging of atherosclerotic lesions and speculate on their applicability in the clinical setting...
  18. ncbi Regulation of coagulation by protein S
    Elisabetta Castoldi
    Department of Biochemistry, Cardiovascular Research Institute Maastricht CARIM, Maastricht University, Maastricht, The Netherlands
    Curr Opin Hematol 15:529-36. 2008
    ..In this review, the regulation of thrombin generation by protein S and the pathophysiological implications of protein S deficiency are discussed in the light of recent findings on the anticoagulant function(s) of protein S...
  19. ncbi Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction
    Hilde Laeremans
    Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, Maastricht University, 50 Universiteitssingel, 6229ER Maastricht PO Box 616, 6200MD Maastricht, Netherlands
    Circulation 124:1626-35. 2011
    ..In this study, we evaluated Frizzled as a novel therapeutic target for MI. These Frizzled proteins act as receptors for Wnt proteins and were previously shown to be expressed in the healing infarct...
  20. ncbi Nepsilon-(thiaprolyl)-lysine as a handle for site-specific protein conjugation
    Pieter Van de Vijver
    Department of Biochemistry, Cardiovascular Research Institute Maastricht, University Maastricht, The Netherlands
    Biopolymers 94:465-74. 2010
    ..This side chain protection strategy enables the use of readily available thiol-reactive probes for the modification of internally disulfide bonded proteins...
  21. ncbi Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency
    Elisabetta Castoldi
    Department of Biochemistry, Maastricht University P O Box 616, 6200 Maastricht, The Netherlands
    Haematologica 95:1563-71. 2010
    ....
  22. ncbi Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling
    Kitty B J M Cleutjens
    Department of Pathology, Cardiovascular Research Institute Maastricht CARIM, University of Maastricht, Maastricht, The Netherlands
    J Clin Invest 118:2979-85. 2008
    ....
  23. ncbi The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification
    Ellen C M Cranenburg
    VitaK, Maastricht University, Maastricht, The Netherlands
    J Vasc Res 45:427-36. 2008
    ..Here we report on the development of an ucMGP assay and the potential diagnostic utility of monitoring serum ucMGP levels...
  24. ncbi Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots
    Lenneke Prinzen
    Department of Biophysics, University of Maastricht, and Department of Radiology, University Hospital Maastricht, The Netherlands
    Nano Lett 7:93-100. 2007
    ..The nanoparticle is suitable for both anatomic and subcellular imaging of structures in the vessel wall and is a promising bimodal contrast agent for future in vivo imaging studies...
  25. ncbi Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes
    Merlijn J P M T Meens
    Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht CARIM, Maastricht University, Maastricht, The Netherlands
    PLoS ONE 5:e10917. 2010
    ..We tested whether the quasi-irreversible receptor-binding of ET-1 (i) limits reversing effects of the antagonists and (ii) can be selectively dissociated by an endogenous counterbalancing mechanism...
  26. ncbi Nucleophilic catalysis of hydrazone formation and transimination: implications for dynamic covalent chemistry
    Anouk Dirksen
    Department of Cell Biology, Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA
    J Am Chem Soc 128:15602-3. 2006
    ..The strong enhancement in the rate of hydrazone equilibration broadens the scope of this stable imine in the field of dynamic covalent chemistry...
  27. ncbi cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo
    Alexandra Buehler
    CARIM, University of Maastricht, Maastricht, The Netherlands
    Arterioscler Thromb Vasc Biol 26:2681-7. 2006
    ..Here, we investigated the feasibility of selective imaging of cardiac angiogenesis using the cNGR-CD13/APN system...
  28. ncbi Design and synthesis of a bimodal target-specific contrast agent for angiogenesis
    Anouk Dirksen
    Laboratory of Macromolecular and Organic Chemistry, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands
    Org Lett 6:4857-60. 2004
    ....
  29. ncbi A structural model of the SHBG domain of human variant protein S Heerlen
    Gerry A F Nicolaes
    Thromb Haemost 96:538-40. 2006
  30. ncbi In vivo clearance of human protein S in a mouse model: influence of C4b-binding protein and the Heerlen polymorphism
    Cecile V Denis
    INSERM U 143, Kremlin Bicetre, France
    Arterioscler Thromb Vasc Biol 25:2209-15. 2005
    ..To explore the effect of the Heerlen polymorphism and C4b-binding protein (C4BP) on protein S catabolism in vitro and in vivo...